期刊文献+

前列腺腺癌患者血清PSA水平对Gleason评分的预测价值 被引量:3

The predictive value of serum PSA to Gleason score in patients with prostate adenocarcinoma
下载PDF
导出
摘要 目的 探讨前列腺腺癌患者血清前列腺特异性抗原(PSA)水平对Gleason评分的预测价值.方法 研究血清PSA三种主要指标和Gleason分级主要指标均值;比较不同组别之间的差异,分析血清PSA与Gleason评分相关性,并观察血清总PSA(tP-SA)与Gleason评分之间变化趋势.结果 血清tPSA≤4.0、4.1~10.0、10.1~20.0、20.1~100.0、>100.0 ng/mL组Gleason评分均值分别为6.31±0.47、6.66±0.89、7.04±1.11、7.56±1.03以及7.91±1.01;血清游离PSA(fPSA)≤1.0、1.1~10.0、>10.0组Gleason评分均值分别为6.45±0.69、6.98±0.98以及7.75±1.05;血清总PSA(tPSA) t/fPSA≤0.16、0.17~0.50以及>0.50组Gleason评分均值分别为6.72±0.88、7.45±1.04以及8.36±1.12.血清tPSA、fPSA以及fPSA/tPSA比值分别与Gleason评分、主要分级以及次要分级显著正相关;Gleason评分、主要分级以及次要分级均随血清tPSA、fPSA以及fPSA/tPSA逐渐增加而增加.结论 前列腺腺癌患者血清PSA对Gleason评分的具有预测价值;与fPSA和fPSA/tPSA比值相比,tPSA是最有预测价值的指标. Objective To investigate the predictive value of the Gleason score to serum prostate specific antigen (PSA) in patients with prostate adenocarcinoma. Methods The mean level of 3 major indicators of serum PSA and Gleason score were studied and compared, the correlation between serum PSA and Gleason score was analyzed, and changes of serum PSA and G1- eason score were observed. Results When serum tPSAwas≤ 4.0, 4.1-10.0, 1-20.0, 20.1-100.0 and〉100.0 ng/mL, the average Gleason score was 6.31±0.47, 6.66±0.89, 7.04±1.11, 7.56±1.03 and 7.91±1.01. When serum fPSA was 1.0, 1.1-5.0, 〉5.0 ng/mL, the average Gleason score was 6.45± 0.69, 6.98± 0.98 and 7.75±1.05. When serum fPSA/tP- SA≤0.16, 0.17-0.50 and〉0.50, the average Gleason score was 6. 72± 0.88, 7.45±1.04 and 8.36±0.50. The serum t PSA, fPSA and fPSA/tPSA were significantly positively related to Gleason score, the primary grade and secondary grade. Oonclu- sions The serum PSA was useful to predict Gleason score in patients with prostate adenocarcinoma. Compared with fPSA and t/fPSA, tPSA is the most usefully predictive indicator.
出处 《现代泌尿外科杂志》 CAS 2014年第10期644-647,657,共5页 Journal of Modern Urology
关键词 前列腺腺癌 前列腺特异性抗原 GLEASON评分 预测 prostate adenocarcinoma prostate specific antigen (PSA) Gleason score prediction
  • 相关文献

参考文献13

  • 1MCGUIRE BB,HELFAND BT,LOEB S,et al.Outcomes in patients with Gleason score 8-10 prostate cancer:relation to preoperative PSA level[J].BJU Int,2012,109(12):1764-1769.
  • 2ZIVKOVIC S,VELICKVIC L,KOSTOV M,et al.Relation of serum prostate-specific antigen and the Gleason grade in patients with pros tatic carcinoma[J].Vojnosanit Pregl,2003,60 (4):449-454.
  • 3谢立平,蒋建平,沈华锋,郑祥毅,秦杰,张晨光,白宇,陈昭典,蔡松良,张志根,任国平,王丽君,余心如.前列腺癌血清PSA、f/tPSA与Gleason评分、临床分期的相关性研究[J].中国男科学杂志,2007,21(3):14-17. 被引量:12
  • 4ELABBADY AA,KHEDR MM.Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3-10 ng/ml[J].Int UrolNephrol,2006,38(3-4):553-557.
  • 5白安胜,汪峰,贾军琪,郭巍,强亚勇,张春莉.前列腺增生症患者合并前列腺炎对血清PSA的影响[J].现代泌尿外科杂志,2012,17(2):177-179. 被引量:18
  • 6PARK DS,HONG JY,HONG YK,et al.Correlation between serum prostate specific antigen level and prostate volume in a community-based cohort:large-scale screening of 35,223 Korean Men[J].Urology,2013,82(6):1394-1399.
  • 7肖芹,印洪林,陆珍凤,孟奎,周晓军.前列腺癌Gleason分级评分与血清PSA、原位PSA的变化和34βE12、P504S免疫表型的研究[J].中华男科学杂志,2004,10(5):362-365. 被引量:16
  • 8邓晓俊,郎根强,章益峰,褚健,庄剑秋,曹建伟.PSAD在PSA 4~10ng患者前列腺癌诊断中的价值[J].现代泌尿外科杂志,2012,17(1):58-60. 被引量:13
  • 9PELTOLAel MT,NIEMELA P,VAISANEN V,et al.Intact and internally cleaved free prostate-specific antigen in patients with prostate cancer with different pathologic stages and grades[J].Urology,2011,77(4),1009,1-8.
  • 10KAPOOR N,JAIN R,SURANGE S,et al.Prostate specific antigen ratio:for diagnosis and assessment of aggressiveness of malignancy of prostate[J].Indian J Pathol Microbiol,2006,49 (2):178-181.

二级参考文献41

  • 1PRESTI TC JR, CHANG JJ, BHARGAVA V,et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies:results of a prospective clinical trial [J]. J Urol, 2000, 163 (1):163-166.
  • 2JANI AB, JOHNSTONE PA, LIAUW SL, et al. Age and grade trends in prostate cancer (1974-2003), a surveillance, epidemiology and end results registry ananlysis [J]. Am J Clin Oncol, 2008, 31 (4):375-378.
  • 3YAMAMOTO S, MARUYAMA T, KONDOH N,et al.Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity,singly and in combination,in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng/mL[J].Int Urol Nephrol,2008,40(1):85-89.
  • 4STEPHAN C, JUNK K, LEIN M, et al. PSA and other tissue kallikreins for prostate cancer detection [J]. Eur J Cancer, 2007, 43 (13):1918-1926.
  • 5JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics 2008[J]. CA Cancer J Clin,2008, 58:71-96.
  • 6ETZIONI R, TSODIKOV A, MARIOTTO A, et al. Quanifying the role of PSA screening in the US prostate cancer mortality decline[J]. Cancer Causes Cantrol, 2008, 19:175-181.
  • 7TOMIOKA S, SHIMBO M, AMIVA Y, et al. Significance of prostate-specific antigen-doubling time on survial of patients with hormone refractory prostate cancer and bone metastasis:analysis on 56 cases of cancer-specific death[J]. Int J Urol, 2007,14 (2):123-127.
  • 8LEE SE, CHUNG JS, HAN BK, et al. Relationship of prostate-specific antigen and prostate volume in Korean men with biopsy-proven benign prostatic hyperplasia[J]. Urology, 2008,71(3):395-398.
  • 9LOEB S, CATALONA WJ. Prostate-specific antigen in clinical practice[R]. Cancer Lett, 2007, 249 (1):30-39.
  • 10BENSON MC, WHANG IS, PANTUNK A, et al. Prostate specific antigen denisity:a means for distinguishing beign prostatic hypertrophy and prostate cancer [J]. J Urol, 1992, 147:815-816.

共引文献54

同被引文献27

  • 1谢立平,蒋建平,沈华锋,郑祥毅,秦杰,张晨光,白宇,陈昭典,蔡松良,张志根,任国平,王丽君,余心如.前列腺癌血清PSA、f/tPSA与Gleason评分、临床分期的相关性研究[J].中国男科学杂志,2007,21(3):14-17. 被引量:12
  • 2JEMAJ A,BRAY F,CENTER MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
  • 3DAVIES JD,AGHAZADEH MA, PHILLIPS S,et al.Prostate size as a predictor of Gleason Gcore upgrading in patients with low risk prostate cancer[J]. J Urol, 2011,186(6):2221-2227.
  • 4EROGLU M, DOLUOGLU OG, SARICI H, et al.Does the time from biopsy to radical prostatectomy affect Gleason Score upgrading in patients with clinical T1c prostate cancer? [J].Korean J Urol,2014,55.(6):395-399.
  • 5SARICI H, TELLI O, YIGITBASI O, et al.Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6[J]. Can Urol Assoc J,2014,8(5-6):E342-346.
  • 6CORCORAN NM,HONG MK,CASEY RG,et al.Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence[J].BJU Int,2011,108(8 Pt 2):E202-E210.
  • 7RICHSTONE L, BIANCO FJ, SHAH HH, et al. Radical prostatectomy in men aged>or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram [J]. BJU Int,2008,101:541-546.
  • 8BRIGHT E, MANUEL C, GODDARD JC, et al. Incidence and variables predicting Gleason score up-grading between trans-rectal ultrasound-guided prostate biopsies and radical prostatectomy [J]. Urol Int,2010,84:180-184.
  • 9GERSHMAN B, DAHL DM, OLUMI AF, et al. Smaller prostate gland size and older age predict Gleason score upgrading[J]. Urol Oncol,2013,31:1033-1037.
  • 10EPSTEIN JI, FENG Z, TROCK BJ,et al.Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy:incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades[J].Eur Urol,2012,61(5):1019-1024.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部